Literature DB >> 7541717

Insulin-like growth factor II is an experimental stress inducible gene in a porcine model of brief coronary occlusions.

A Kluge1, R Zimmermann, B Münkel, P D Verdouw, J Schaper, W Schaper.   

Abstract

OBJECTIVE: Previous observations have shown that myocardium activates many adaptive processes after brief ischaemia. The aim of this study was to determine whether insulin-like growth factors (IGF) as well as their receptors and binding proteins (IGFBP), which control the activity of the IGF, may play an important role during these processes.
METHODS: Ischaemia was induced in anaesthetised open chest pigs by two 10 min occlusions of the left anterior descending coronary artery, separated by 30 min of reperfusion, and followed by reperfusion up to 210 min. Tissue from the ischaemic area and from a non-ischaemic control region of the same heart was examined by means of northern blot, slot blot, and in situ hybridisation.
RESULTS: IGF-I, IGF-II, the type I receptor, the insulin receptor, and IGFBP-2-6 are constitutively expressed in porcine myocardium. In situ hybridisation showed that IGF-I and IGF-II are mainly transcribed by myocytes. Ischaemia/reperfusion led to an early and significant increase in IGF-II mRNA compared to non-sham controls but not in comparison with sham operated animals, which already showed a (not significantly) enhanced IGF-II expression. In each case the IGF-II mRNA levels are equal in the control and the experimental region of the same heart. Whereas IGF-II expression was already increased by experimental stress, IGFBP-5 mRNA was enhanced only by ischaemia/reperfusion. The expression of IGF-I, the receptors, and IGFBP-2, 3, 4, and 6 remained unchanged during the experimental protocol. IGFBP-1 was neither expressed nor induced in our model.
CONCLUSIONS: IGF-II acts like a stress-response gene activated by the experimental conditions (surgery, anaesthesia) and remains induced during following episodes of ischaemia/reperfusion. A possible interaction of IGFBP-5 with other components of the IGF system may contribute to the preconditioning response.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541717

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  7 in total

Review 1.  Ischemic preconditioning, remembrances of things past and future.

Authors:  W Schaper
Journal:  Basic Res Cardiol       Date:  1996 Jan-Feb       Impact factor: 17.165

2.  Dung-Shen Downregulates the Synergistic Apoptotic Effects of Angiotensin II Plus Leu 27-IGF II on Cardiomyoblasts.

Authors:  Ko-Shih Chang; Nien-Hung Lee; Wei-Wen Kuo; Wei-Syun Hu; Mu-Hsin Chang; Fuu-Jen Tsai; Kun-Hsi Tsai; Yuh-Shyong Yang; Tung-Sheng Chen; Chih-Yang Huang
Journal:  Acta Cardiol Sin       Date:  2014-01       Impact factor: 2.672

3.  Gene expression after short periods of coronary occlusion.

Authors:  E Deindl; W Schaper
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

4.  Abnormal Igf2 gene in Prague hereditary hypertriglyceridemic rats: its relation to blood pressure and plasma lipids.

Authors:  Michaela Kadlecová; Zdenka Dobesová; Josef Zicha; Jaroslav Kunes
Journal:  Mol Cell Biochem       Date:  2008-04-17       Impact factor: 3.396

5.  Genome-wide association study of perioperative myocardial infarction after coronary artery bypass surgery.

Authors:  Miklos D Kertai; Yi-Ju Li; Yen-Wei Li; Yunqi Ji; John Alexander; Mark F Newman; Peter K Smith; Diane Joseph; Joseph P Mathew; Mihai V Podgoreanu
Journal:  BMJ Open       Date:  2015-05-06       Impact factor: 2.692

6.  Type-specific dysregulation of matrix metalloproteinases and their tissue inhibitors in end-stage heart failure patients: relationship between MMP-10 and LV remodelling.

Authors:  Yingjie Wei; Chuanjue Cui; Mitja Lainscak; Xiaoling Zhang; Jun Li; Jie Huang; Hao Zhang; Zhe Zheng; Shengshou Hu
Journal:  J Cell Mol Med       Date:  2011-04       Impact factor: 5.310

Review 7.  Current IGFBP-Related Biomarker Research in Cardiovascular Disease-We Need More Structural and Functional Information in Clinical Studies.

Authors:  Andreas Hoeflich; Robert David; Rikke Hjortebjerg
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-16       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.